Sepsis remains one of the leading causes of death in children worldwide, arising when an infection triggers a dysregulated immune response that damages the body’s own organs. In adults, clinicians have long recognized that the liver is both a victim and a signal in this process. Hepatic dysfunction in adult sepsis is considered an independent predictor of mortality, meaning that even after accounting for other factors, a failing liver marks a patient at elevated risk. Whether the same holds true for children, however, had never been systematically examined. Individual pediatric studies had reported varying rates of liver injury and conflicting associations with death, but no one had pooled the data. The Indonesian team registered their review prospectively with PROSPERO under the identifier CRD420261387360 and searched five major databases, including PubMed, Scopus, MEDLINE via EBSCO, the Cochrane Library, and ClinicalTrials.gov, from their inception through 21 May 2026, without language restrictions. Notably, Embase was not searched, a limitation the authors acknowledge.

The eligibility criteria were strict. Studies had to enroll children aged one month to 18 years, define sepsis according to consensus criteria, and report outcomes stratified by the presence or absence of liver injury. Two reviewers independently screened records and extracted data, a standard safeguard against individual error. Risk of bias was evaluated using two prespecified instruments: the Newcastle-Ottawa Scale for the observational studies included in the mortality analysis and the Quality in Prognosis Studies tool, known as QUIPS, which is specifically designed for prognostic research. Statistical pooling employed a Mantel-Haenszel random effects model for mortality odds ratios, while the proportion of children developing liver injury was estimated with a logistic-normal generalized linear mixed model, an approach better suited to proportions than naive averaging. Certainty of the evidence was graded using GRADE, the framework that rates confidence in findings from high to very low.

After screening, ten studies made the final cut. The headline result came from five of these studies, encompassing 1,717 children, that reported mortality according to liver injury status. Pooling their unadjusted data, the researchers found that children with SALI had nearly four times the odds of dying compared with those without it, with an odds ratio of 3.88 and a 95 percent confidence interval of 2.21 to 6.80. Three of the studies measured death during hospital admission, one measured death in the pediatric intensive care unit, and one did not specify the timing. On the surface, this is a striking signal: a liver under assault during sepsis appears to mark a child in grave danger.

But the statistical fine print tells a more cautious story. The prediction interval, which estimates the range of true effects one might expect in future studies, stretched from 0.63 to 23.80, crossing the value of 1.0 that would indicate no association at all. In other words, some future pediatric population might show no link between liver injury and death, while another might show an enormous one. The Hartung-Knapp adjusted confidence interval, a more conservative calculation that accounts for uncertainty in the between-study variance, widened further to 1.65 to 9.12. Combined with a GRADE rating of very low certainty, these numbers mean clinicians should treat the fourfold figure as a hypothesis-generating signal rather than a settled fact. The heterogeneity across studies, likely driven by different definitions of liver injury, different patient populations, and different measurement schedules, is substantial enough to temper any confident clinical claim.

The deeper problem is confounding by severity. Children whose livers fail during sepsis are, almost by definition, sicker than children whose livers hold out. Two of the included studies attempted to address this statistically. Saini and colleagues reported that SALI remained associated with mortality after adjustment for selected clinical covariates, but their mortality model did not include pSOFA, the pediatric Sequential Organ Failure Assessment score, or any other validated global severity measure. Without such a score, it is impossible to know whether the liver adds information beyond what general illness severity already captures. Only Koca and colleagues adjusted hepatic markers for validated pediatric severity scores, namely PRISM III, the Pediatric Risk of Mortality Score, and PELOD-2, the Pediatric Logistic Organ Dysfunction Score. In that analysis, neither alanine aminotransferase, the enzyme ALT commonly used to detect liver cell damage, nor total bilirubin, the pigment that accumulates when the liver fails to clear it, remained independently associated with death. Once a child’s overall severity was accounted for, the liver’s apparent prognostic power evaporated.

Beyond mortality, the review also estimated how often liver injury occurs in pediatric sepsis at all. Across seven studies covering 1,876 children, the pooled proportion was 29 percent, with a wide 95 percent confidence interval of 17 to 46 percent. That range is itself informative: it reveals how inconsistently SALI is defined and detected across the pediatric literature. Some studies may rely on a single elevated transaminase value, others on bilirubin thresholds, and still others on composite criteria, and the timing of measurement during the septic episode varies just as widely. The authors argue that this heterogeneity makes a strong case for standardized pediatric definitions of sepsis-associated liver injury and for agreed ascertainment schedules, so that future studies measure the same thing at the same moments. The Pediatric Organ Dysfunction Information Update Mandate, or PODIUM, represents one ongoing effort to bring consistency to organ dysfunction definitions in pediatric critical care.

The review also examined candidate biomarkers that might identify liver injury or predict outcomes earlier than conventional tests. The most promising was APRI, the AST-to-platelet ratio index, a simple calculation combining aspartate aminotransferase levels with platelet counts. In two cohorts, APRI showed areas under the receiver operating characteristic curve, or AUROCs, of 0.83 to 0.89, values generally considered good discriminative ability. Yet the authors urge caution on two fronts. First, the diagnostic thresholds differed substantially between the two cohorts, meaning a child classified as having liver injury by one study’s cutoff might be classified as normal by another’s. Second, the APRI is built on AST, while the outcome definitions in these studies were based on ALT, creating an overlap problem that limits how the biomarker’s performance can be interpreted. Other markers examined in the underlying studies, including lactate dehydrogenase, apolipoprotein A-V, and the albumin-corrected anion gap, remain at even earlier stages of evaluation. The authors conclude that no candidate biomarker is ready for clinical use without prospective multicenter validation.

What does this mean for the pediatric intensivist at the bedside? The practical takeaway is nuanced. An elevated ALT or bilirubin in a septic child should certainly prompt attention, and the unadjusted association suggests these children warrant heightened vigilance. But the evidence does not yet support treating liver injury as an independent prognostic marker that adds value beyond established severity scores such as PRISM III, PELOD-2, or pSOFA. The honest answer to whether hepatic dysfunction carries prognostic information of its own is that nobody currently knows, and the review makes that uncertainty explicit rather than papering over it. This kind of transparency is increasingly valued in evidence-based medicine, where overconfident meta-analytic estimates can mislead practice as surely as absent evidence can.

The study, published open access on 7 October 2026 and available under a Creative Commons license, received no external funding and its authors declare no competing interests. Its limitations are clearly stated: only ten studies were available, Embase was not searched, adjusted analyses were rare, and the underlying literature is dominated by observational designs vulnerable to confounding. The research team, which also included Ade Gautama and Khanyfah Syagita, notes with gratitude that Dr. Abdulkerim Elmas provided unpublished subgroup data through personal correspondence, strengthening the primary mortality analysis. For now, the review stands as both a warning and a roadmap: liver injury during pediatric sepsis is common, appears dangerous, and demands rigorous, standardized study before it can be woven into the scoring systems that guide care for the world’s sickest children.

Subject of Research: Sepsis-associated liver injury and mortality outcomes in children

Article Title: Sepsis-associated liver injury and clinical outcomes in children: a systematic review and meta-analysis

Article References: Wiriadinata, N. E. R., Gautama, A., Syagita, K., & Oswari, H. (2026). Sepsis-associated liver injury and clinical outcomes in children: a systematic review and meta-analysis. BMC Pediatrics. https://doi.org/10.1186/s12887-026-07775-6

Image Credits: AI Generated

DOI: 10.1186/s12887-026-07775-6

Keywords: sepsis, liver injury, pediatrics, meta-analysis, mortality, PICU, biomarkers, APRI, PRISM III, PELOD-2, pSOFA, systematic review

The demographic picture is stark. In China, annual births declined steadily from 2018 through 2025, falling far beneath the population replacement threshold. The authors document how some Chinese medical institutions have already closed or downsized their pediatric departments as the patient base contracts. A case study of three Chinese children’s hospitals at different tiers between 2023 and 2025 revealed declining patient volumes, a shrinking proportion of infants under one year old, and a rising median age among children admitted to intensive care. Similar patterns appear across East Asia: Japan and South Korea, both representative low-birth-rate nations, have experienced sustained declines in pediatric outpatient visits. These shifts are not abstract statistics; they directly alter the age distribution and clinical complexity of children arriving in PICUs, changing the case mix that units were designed and staffed to handle.

Historically, pediatric critical care in China developed under a scale-driven logic in which expanding service volume was the key to reducing per-case costs, sustaining operations, and training the next generation of intensivists. That logic now faces a structural headwind. The authors warn that declining births could trigger an adverse development cycle in which shrinking revenues force cutbacks, cutbacks degrade training and quality, and degraded quality further erodes both workforce morale and public trust, ultimately regressing the equity, rationality, and fairness of medical resource distribution. International evidence suggests the risk is real. Data from 983 United States emergency departments show that the unit operating cost in low-volume pediatric departments is more than 70 times higher than in high-volume settings. In Japan, between 2010 and 2022, only 37 percent of children requiring mechanical ventilation were admitted to an ICU environment, a shortfall the authors attribute to resource constraints.

The workforce challenge may be the most acute. Training and retaining pediatric intensivists is a prolonged, high-demand process marked by intense workloads, relatively low compensation, and limited career appeal, producing a global shortage of senior talent. A multinational survey of 146 ICUs admitting pediatric patients found that only 52.7 percent had pediatric intensivists available around the clock. In China, the attrition rate among pediatricians reached 10.7 percent between 2011 and 2014, a figure that predates the steepest phase of the birth-rate decline. Financial strain compounds the problem. During the COVID-19 pandemic, rural township hospitals in two Chinese counties saw combined outpatient and inpatient visits fall by 40 to 50 percent, accompanied by a 50 percent reduction in annual revenue, a preview of the economic pressure that sustained demographic decline could impose on pediatric services everywhere.

Triage mechanisms and equity concerns add another layer of complexity. The United States operates a market-based, mandatory insurance system that has drawn criticism for coverage gaps and poor primary care accessibility; between 2008 and 2018, roughly one-fifth of U.S. hospitals closed their pediatric departments, significantly reducing services in rural and low-volume urban areas and compromising care for children with medical complexity. China advocates a non-mandatory model built on initial primary care consultation and bidirectional referrals, but the system struggles with a well-documented siphoning effect in which top-tier hospitals attract a disproportionate share of patients, leaving primary care capabilities as a significant bottleneck. The authors argue that without scientifically driven hierarchical diagnosis and treatment mechanisms, declining volumes will hit smaller institutions hardest, deepening geographic and socioeconomic disparities in access to critical care.

Yet the paper is not a eulogy; it is a strategy. The authors identify substantial opportunities. Policy support is expanding: the United States and South Korea are addressing pediatrician income through raised service fees and diversified revenue streams, while China has introduced salary incentives, optimization of service networks, and adjustments to medical insurance pricing. Clinical capability continues to advance, with mortality from pediatric acute necrotizing encephalopathy in China dropping from 50.0 percent to 16.7 percent, and mortality from pediatric septic shock falling from 47.4 percent to 23.4 percent, gains attributed to knowledge updates, optimized treatment strategies, and enhanced service capacity. Artificial intelligence is beginning to demonstrate measurable value, assisting in reducing sepsis mortality and shortening hospital stays, lowering the incidence of several perinatal maternal and infant diseases, and enabling personalized pain management for children, though the authors caution that inconsistent data quality, limited algorithmic interpretability, and high implementation costs demand precise adaptation to clinical scenarios rather than indiscriminate deployment.

Collaborative networks represent another promising frontier. Germany has established a pediatric surveillance network covering nearly all children’s hospitals, enabling nationwide observational studies and providing a basis for PICU functional tiering and certification. China is pursuing parallel efforts through hospital alliances, including PICU quality control standards, large-sample databases, and multicenter cohort studies. The authors also highlight integration into a life-course health system, an approach championed by both the World Health Organization and the Chinese government. Italian experience shows that community-based primary care networks supported by tertiary pediatric centers optimize resource allocation and enhance service continuity, while Singapore has developed a full-chain hospital-to-community model for perinatal and pediatric palliative care. PICUs, the authors suggest, can extend their services into outpatient, home-based, and telemedicine care, reducing the burden of hospitalization while improving the patient experience.

At the heart of the paper lies a conceptual framework. Resilience, defined as the core capacity to withstand shocks such as patient volume fluctuations, financial pressure, and talent attrition, spans three dimensions: human resources, emphasizing stability and long-term workforce growth; financial health, achieved through subsidies, cost control, and service enhancement; and clinical strength, prioritizing quality over quantity by advancing treatment of complex cases. Efficacy, in turn, refers to the transformation of opportunities into new capabilities across technology, including AI, telemedicine, and translational research; collaboration, through data sharing and institutional partnerships; and value, measured by improved cure rates and life-course care. Crucially, the authors stress that resilience and efficacy are mutually dependent and reinforcing: a unit that cannot survive shocks cannot innovate, and a unit that fails to innovate cannot remain resilient.

From this framework the authors derive three core pathways. First, governments and the healthcare sector must provide sustained technical and capacity support for tiered diagnosis and treatment, establishing clinical standards, organizing skills training, and partnering with technology enterprises on telemedicine and smart referral systems, supported by strong policy guidance and medical insurance payment reform. Second, innovation serves as the pivotal enabler: the Baichuan pediatric AI model, developed under the leadership of Beijing Children’s Hospital, has achieved a diagnostic accuracy of 82 percent and been deployed in more than 150 hospitals across China, while a South Korean digital platform for optimal hospital referral has reduced patient mortality rates. Third, data integration is the foundation of synergistic efficacy; institutions such as Beijing Children’s Hospital and Fudan University Children’s Hospital have published pivotal large-scale data research in journals including The Lancet and JAMA, yet systemic barriers around data sharing, standardized protocols, and incentives persist and require government-led standards and collaboration.

The authors are candid about the limits of their analysis. The core arguments lack robust evidence and financial modeling, the proposed pathways are constrained by limited interdisciplinary integration across operations, governance, and economics, and the paper does not address acceptance within the PICU community, risk assessment, specific talent development strategies, or selection bias in the literature. Frontier therapies such as brain-computer interfaces, cell therapy, and gene editing remain hampered by insufficient evidence, low accessibility, and incomplete ethical guidelines. What the paper offers, instead, is a conceptual framework and preliminary roadmap, an invitation to the global pediatric critical care community to rethink how life-saving infrastructure can endure when the population it serves is shrinking. As birth rates continue to fall worldwide, the question of whether intensive care for children can become both tougher and smarter may define the specialty’s next quarter century.

Subject of Research: Strategies for sustaining pediatric intensive care services amid declining birth rates

Article Title: Toward resilient and efficient pediatric critical care provision amid falling birth rates

Article References: Liu, G., Wang, Q., & Qian, S.-Y. (2026). Toward resilient and efficient pediatric critical care provision amid falling birth rates. World Journal of Pediatrics. https://doi.org/10.1007/s12519-026-01087-6

Image Credits: AI Generated

DOI: 10.1007/s12519-026-01087-6

Keywords: pediatric intensive care, falling birth rates, PICU, healthcare workforce, artificial intelligence, tiered diagnosis, health equity, resilience, efficiency, China, life-course health, data sharing